RankAlpha logo
Back to Rankings

LUNG

PulmonxC
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
View Chart
Current thesis
The best post-print bull read would be confirmation that first-quarter demand did not deteriorate versus the March setup, especially if management can keep 2026 revenue guidance intact while showing operating-expense discipline and no sharper-than-planned cash burn.
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
2026 revenue guidance of $90 million-$92 million is only around flat with 2025 revenue of $90.5 million, which is a modest setup for a company that still needs adoption-driven growth to escape balance-sheet scrutiny.
Momentum
82
Value
36
Sentiment
30
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.00 · Bull $2.40 · Bear $0.50
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $5.75
Why
Momentum82 · Δ7d -
Value36 · Δ7d -0.0
Sentiment30 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
82
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
30
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade C. Momentum 81.6 / Value 36.3 / Sentiment 30.4

Fundamentals (TTM)
As of 2026-06-02
Market Cap
$68M
Beta
0.08
Shares Out
41.25M
P/E (TTM) · Derived
-1.1
P/S (TTM)
1.01
P/FCF (TTM) · Derived
-2.04
Rev YoY
+5.5%
EPS YoY
+5.3%
Gross Margin
+73.3%
Op Margin
-62.4%
Net Debt
-$64.3M
Current Ratio
4.86
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology